Le Lézard
Classified in: Health
Subjects: BFA, BLK, DEI

Janssen's Save Legs. Change Lives.tm is Creating a More Equitable Future for Communities at Risk of PAD-Related Amputations


Black Americans are up to four times more likely to have a PAD-related amputation,1 largely due to greater delays in care2 and less access to quality vascular care1

Save Legs. Change Lives.tm aims to reach more than 10 million Black Americans over the multi-year initiative

TITUSVILLE, N.J., Nov. 4, 2022 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the first impact summary for its Save Legs. Change Lives.tm Spot Peripheral Artery Disease Now multi-year initiative, designed to create urgency and action around the hidden threat of peripheral artery disease (PAD)-related amputation. In its inaugural year, Save Legs. Change Lives.tm focused on reaching Black Americans, who are up to four times more likely than white Americans to have a PAD-related amputation.1 With this critical initiative, Janssen is focused on helping those at risk of PAD through more than 12 programs across three focus areas: empowering individuals and communities placed at an increased risk of PAD, collaborating with powerful partners, and driving research.

Experience the full interactive Multichannel News Release here: https://www.multivu.com/players/English/9106651-janssen-save-legs-change-lives-initiative/